Key points are not available for this paper at this time.
Patients with favorable prognosis of breast cancer are vulnerable to overtreatment because the absolute net benefit of different treatments may be small and difficult to quantify in individual cases. Advances in personalized treatment hold the promise of increasing the certainty of the treatment benefit of different treatments in individual patients, but insufficient attention has been paid to the challenges to treatment decision‐making.
Katz et al. (Fri,) studied this question.